The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations…
LIVTENCITY (maribavir) is now listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with post-transplant cytomegalovirus (CMV) infection or…
QUEENSLANDERS now have permanent access to a broader range of health services for everyday conditions through participating community pharmacies, making…